Profile
Sector:
Basic MaterialsIndustry:
Specialty ChemicalsCountry:
United StatesIPO:
03 May 2016Website:
http://www.ingevity.comNext earnings report:
21 February 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 20 Nov 2024 22:59:42 GMTDividend
Analysts recommendations
Institutional Ownership
NGVT Latest News
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced today that it will release its third-quarter 2024 earnings after the stock market close on Tuesday, October 29, 2024.
Ingevity (NGVT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity today announced that John Fortson has departed as president and CEO and from the board of directors of the company.
The Capa HS series is the latest example of NGVT's current innovation push, which is extending the performance boundaries of Caprolactone technology.
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity participates in EU FEICA EXPO 2024, launches Capa L, the next generation of sustainable polycaprolactone polyols for polyurethane adhesives.
Ingevity's (NGVT) top line declines in Q2 due to the Performance Chemicals segment's repositioning, which included limiting exposure to specific markets within the Industrial Specialties product line.
Ingevity Corporation (NYSE:NGVT ) Q2 2024 Earnings Conference Call August 1, 2024 11:00 AM ET Company Participants John Nypaver - VP, Treasurer & IR John Fortson - President, CEO & Director Mary Hall - CFO, EVP & Treasurer Conference Call Participants John McNulty - BMO Capital Markets Daniel Rizzo - Jefferies Jonathan Tanwanteng - CJS Securities Mike Sison - Wells Fargo Operator Good morning all and thank you all for attending the Ingevity Second Quarter 2024 Earnings Call and Webcast. My name is Brika, and I will be your moderator today.
Ingevity (NGVT) came out with quarterly earnings of $1.01 per share, missing the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.41 per share a year ago.
The addition of a new distribution partner in Europe devoted to Ingevity's (NGVT) Capa biodegradable thermoplastics allows the company to better service its customers in the region.
- 1(current)
- 2
What type of business is Ingevity?
Ingevity Corporation is a manufacturer of specialty chemicals and high-performance materials made from activated carbon. The Performance Materials segment produces products in the form of powders, granules, extruded pellets, honeycombs, and sheets of activated carbon. These products are used in the automotive industry - in gasoline vapor emission control systems, in process purification systems in the food industry, food industry, water purification, and chemical purification. The Performance Chemicals segment includes technologies for road coatings, a range of oilfield technology products, special industrial products, and engineering polymer product lines. The company was founded in 2015, headquartered in North Charleston, South Carolina.
What sector is Ingevity in?
Ingevity is in the Basic Materials sector
What industry is Ingevity in?
Ingevity is in the Specialty Chemicals industry
What country is Ingevity from?
Ingevity is headquartered in United States
When did Ingevity go public?
Ingevity initial public offering (IPO) was on 03 May 2016
What is Ingevity website?
https://www.ingevity.com
Is Ingevity in the S&P 500?
No, Ingevity is not included in the S&P 500 index
Is Ingevity in the NASDAQ 100?
No, Ingevity is not included in the NASDAQ 100 index
Is Ingevity in the Dow Jones?
No, Ingevity is not included in the Dow Jones index
When was Ingevity the previous earnings report?
No data
When does Ingevity earnings report?
The next expected earnings date for Ingevity is 21 February 2025